Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION • Overview PART 05: MARKET LANDSCAPE • Overview • Market size and forecast • Five forces analysis PART 06: SEGMENTATION BY APPLICATION • Overview • Trisomy • Microdeletions • Others PART 07: SEGMENTATION BY END-USER • Overview • Diagnostic centers • Hospitals PART 08: SEGMENTATION BY GEOGRAPHY • Overview • Regional comparison • NIPT market in Americas • NIPT market in EMEA • NIPT market in APAC • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Increase in acceptance of NIPT • Increase in genetic counseling • Growth of genetic screening programs at births PART 12: VENDOR LANDSCAPE • Competitive scenario • Investment opportunities PART 13: KEY VENDOR ANALYSIS • BGI Genomics • Illumina • Laboratory Corporation of America Holdings • Quest Diagnostics • Other prominent vendors PART 14: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Types of prenatal diagnosis and screening Exhibit 02: Lifecycle of prenatal testing techniques Exhibit 03: Comparative analysis of NIPT with other techniques Exhibit 04: Global NIPT market: Overview 2017-2021 Exhibit 05: Global NIPT market 2016-2021 ($ millions) Exhibit 06: Five forces analysis Exhibit 07: Global NIPT market: Segmentation by application 2016 (% share) Exhibit 08: Global NIPT market: Segmentation by application 2021 (% share) Exhibit 09: Global NIPT market: Segmentation by application 2016-2021 (% share) Exhibit 10: Global NIPT by trisomy market 2016-2021 ($ millions) Exhibit 11: Global NIPT by microdeletions market 2016-2021 ($ millions) Exhibit 12: Global NIPT by others market 2016-2021 ($ millions) Exhibit 13: Global NIPT market: Segmentation by end-user 2016-2021 (% share) Exhibit 14: Global NIPT market by diagnostic centers 2016-2021 ($ millions) Exhibit 15: Global NIPT market by hospitals 2016-2021 ($ millions) Exhibit 16: Global NIPT market: Segmentation by geography 2016-2021 (% share) Exhibit 17: Global NIPT market: Regional comparison Exhibit 18: NIPT market in Americas 2016-2021($ millions) Exhibit 19: NIPT market in Americas: Year-over-year growth 2017-2021 (%) Exhibit 20: NIPT market in EMEA 2016-2021 ($ millions) Exhibit 21: NIPT market in EMEA: Year-over-year growth (%) (2017-2021) Exhibit 22: NIPT market in APAC 2016-2021 ($ million) Exhibit 23: NIPT market in APAC: Year-over-year growth 2017-2021 (%) Exhibit 24: Global NIPT market: Key leading countries Exhibit 25: Global NIPT market: Growth and success factors of vendors Exhibit 26: Global NIPT market: Investment opportunity mapping Exhibit 27: BGI Genomics: Overview Exhibit 28: BGI Genomics: Strength analysis Exhibit 29: BGI Genomics: Strategy assessment Exhibit 30: BGI Genomics opportunity assessment Exhibit 31: Illumina: Overview Exhibit 32: Illumina: Strength analysis Exhibit 33: Illumina: Strategy assessment Exhibit 34: Illumina: Opportunity assessment Exhibit 35: Laboratory Corporation of America Holdings: Overview Exhibit 36: Laboratory Corporation of America Holdings: Strength analysis Exhibit 37: Laboratory Corporation of America Holdings: Strategy assessment Exhibit 38: Laboratory Corporation of America Holdings: Opportunity assessment Exhibit 39: Quest Diagnostics Overview Exhibit 40: Quest Diagnostics: Strength analysis Exhibit 41: Quest Diagnostics: Strategy assessment Exhibit 42: Quest Diagnostics: Opportunity assessment

BGI Genomics, Illumina, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies, Berry Genomics, F. Hoffman-La Roche, LifeCodexx, Natera, and PerkinElmer.